Masimo Price to Book Ratio 2010-2025 | MASI
Historical price to book ratio values for Masimo (MASI) over the last 10 years. The current price to book ratio for Masimo as of May 30, 2025 is 8.99.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Masimo Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-30 | 162.50 | 9.31 | |
| 2025-03-31 | 166.60 | $17.46 | 9.54 |
| 2024-12-31 | 165.30 | $19.63 | 8.42 |
| 2024-09-30 | 133.33 | $27.35 | 4.88 |
| 2024-06-30 | 125.94 | $25.73 | 4.89 |
| 2024-03-31 | 146.85 | $25.71 | 5.71 |
| 2023-12-31 | 117.21 | $25.85 | 4.53 |
| 2023-09-30 | 87.68 | $24.16 | 3.63 |
| 2023-06-30 | 164.55 | $24.78 | 6.64 |
| 2023-03-31 | 184.54 | $25.20 | 7.32 |
| 2022-12-31 | 147.95 | $25.50 | 5.80 |
| 2022-09-30 | 141.16 | $23.81 | 5.93 |
| 2022-06-30 | 130.67 | $22.91 | 5.70 |
| 2022-03-31 | 145.54 | $28.50 | 5.11 |
| 2021-12-31 | 292.78 | $28.03 | 10.44 |
| 2021-09-30 | 270.71 | $26.59 | 10.18 |
| 2021-06-30 | 242.45 | $25.27 | 9.59 |
| 2021-03-31 | 229.66 | $24.15 | 9.51 |
| 2020-12-31 | 268.38 | $25.48 | 10.53 |
| 2020-09-30 | 236.06 | $25.70 | 9.19 |
| 2020-06-30 | 227.99 | $24.47 | 9.32 |
| 2020-03-31 | 177.12 | $23.16 | 7.65 |
| 2019-12-31 | 158.06 | $21.75 | 7.27 |
| 2019-09-30 | 148.79 | $20.67 | 7.20 |
| 2019-06-30 | 148.82 | $19.50 | 7.63 |
| 2019-03-31 | 138.28 | $18.84 | 7.34 |
| 2018-12-31 | 107.37 | $18.26 | 5.88 |
| 2018-09-30 | 124.54 | $17.22 | 7.23 |
| 2018-06-30 | 97.65 | $15.82 | 6.17 |
| 2018-03-31 | 87.95 | $14.80 | 5.94 |
| 2017-12-31 | 84.80 | $14.02 | 6.05 |
| 2017-09-30 | 86.56 | $13.88 | 6.24 |
| 2017-06-30 | 91.18 | $13.66 | 6.68 |
| 2017-03-31 | 93.26 | $12.40 | 7.52 |
| 2016-12-31 | 67.40 | $11.16 | 6.04 |
| 2016-09-30 | 59.49 | $6.71 | 8.87 |
| 2016-06-30 | 52.52 | $5.98 | 8.78 |
| 2016-03-31 | 41.84 | $5.47 | 7.65 |
| 2015-12-31 | 41.51 | $5.53 | 7.51 |
| 2015-09-30 | 38.56 | $5.33 | 7.23 |
| 2015-06-30 | 38.74 | $5.57 | 6.95 |
| 2015-03-31 | 32.98 | $6.17 | 5.34 |
| 2014-12-31 | 26.34 | $5.85 | 4.50 |
| 2014-09-30 | 21.28 | $5.42 | 3.93 |
| 2014-06-30 | 23.60 | $5.83 | 4.05 |
| 2014-03-31 | 27.31 | $6.23 | 4.38 |
| 2013-12-31 | 29.23 | $5.76 | 5.07 |
| 2013-09-30 | 26.64 | $5.55 | 4.80 |
| 2013-06-30 | 21.20 | $5.20 | 4.08 |
| 2013-03-31 | 19.62 | $4.96 | 3.96 |
| 2012-12-31 | 21.01 | $4.81 | 4.37 |
| 2012-09-30 | 23.04 | $5.49 | 4.20 |
| 2012-06-30 | 21.33 | $5.16 | 4.13 |
| 2012-03-31 | 22.28 | $4.84 | 4.60 |
| 2011-12-31 | 17.81 | $4.80 | 3.71 |
| 2011-09-30 | 20.61 | $4.96 | 4.16 |
| 2011-06-30 | 28.28 | $4.66 | 6.07 |
| 2011-03-31 | 31.54 | $4.26 | 7.40 |
| 2010-12-31 | 27.70 | $3.87 | 7.16 |
| 2010-09-30 | 25.42 | $4.20 | 6.05 |
| 2010-06-30 | 22.17 | $3.86 | 5.75 |
| 2010-03-31 | 24.72 | $3.55 | 6.97 |
| 2009-12-31 | 26.37 | $5.01 | 5.27 |
| 2009-09-30 | 22.71 | $4.69 | 4.84 |
| 2009-06-30 | 20.90 | $4.40 | 4.75 |
| 2009-03-31 | 25.12 | $4.11 | 6.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.511B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.191B | 87.25 |
| Thermo Fisher Scientific (TMO) | United States | $152.413B | 18.44 |
| Edwards Lifesciences (EW) | United States | $45.596B | 29.90 |
| Alcon (ALC) | Switzerland | $42.592B | 28.78 |
| IDEXX Laboratories (IDXX) | United States | $41.462B | 47.65 |
| DexCom (DXCM) | United States | $33.274B | 51.43 |
| IQVIA Holdings (IQV) | United States | $24.396B | 13.66 |
| Mettler-Toledo (MTD) | United States | $24.382B | 29.00 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Waters (WAT) | United States | $21.144B | 29.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.666B | 0.00 |
| Hologic (HOLX) | United States | $14.021B | 15.23 |
| Sysmex ADR (SSMXY) | Japan | $10.468B | 29.70 |
| Penumbra (PEN) | United States | $10.283B | 80.71 |
| Globus Medical (GMED) | United States | $7.972B | 19.00 |
| Glaukos (GKOS) | United States | $5.421B | 0.00 |
| Teleflex (TFX) | United States | $5.414B | 8.94 |
| TransMedics (TMDX) | United States | $4.319B | 93.89 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| PROCEPT BioRobotics (PRCT) | United States | $3.082B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.111B | 29.63 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.054B | 23.56 |
| Alphatec Holdings (ATEC) | United States | $1.821B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.200B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.24 |
| SiBone (SIBN) | United States | $0.809B | 0.00 |
| IRadimed (IRMD) | United States | $0.739B | 37.51 |
| Beta Bionics (BBNX) | United States | $0.666B | 0.00 |
| RxSight (RXST) | United States | $0.660B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.571B | 13.38 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.494B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.447B | 11.89 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| NeuroPace (NPCE) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.70 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |